These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28344999)

  • 21. Sustained fetal hemoglobin induction in vivo is achieved by
    Uchida N; Ferrara F; Drysdale CM; Yapundich M; Gamer J; Nassehi T; DiNicola J; Shibata Y; Wielgosz M; Kim YS; Bauler M; Throm RE; Haro-Mora JJ; Demirci S; Bonifacino AC; Krouse AE; Linde NS; Donahue RE; Ryu B; Tisdale JF
    Sci Transl Med; 2021 Apr; 13(591):. PubMed ID: 33910976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases.
    Bjurström CF; Mojadidi M; Phillips J; Kuo C; Lai S; Lill GR; Cooper A; Kaufman M; Urbinati F; Wang X; Hollis RP; Kohn DB
    Mol Ther Nucleic Acids; 2016; 5(8):e351. PubMed ID: 28131278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strict in vivo specificity of the
    Smith EC; Luc S; Croney DM; Woodworth MB; Greig LC; Fujiwara Y; Nguyen M; Sher F; Macklis JD; Bauer DE; Orkin SH
    Blood; 2016 Nov; 128(19):2338-2342. PubMed ID: 27707736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies.
    Humbert O; Peterson CW; Norgaard ZK; Radtke S; Kiem HP
    Mol Ther Methods Clin Dev; 2018 Mar; 8():75-86. PubMed ID: 29276718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin genetics: recent contributions of GWAS and gene editing.
    Smith EC; Orkin SH
    Hum Mol Genet; 2016 Oct; 25(R2):R99-R105. PubMed ID: 27340226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations.
    Samuelson C; Radtke S; Zhu H; Llewellyn M; Fields E; Cook S; Huang MW; Jerome KR; Kiem HP; Humbert O
    Mol Ther Methods Clin Dev; 2021 Dec; 23():507-523. PubMed ID: 34853798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic sensor O-GlcNAcylation regulates erythroid differentiation and globin production via BCL11A.
    Luanpitpong S; Kang X; Janan M; Thumanu K; Li J; Kheolamai P; Issaragrisil S
    Stem Cell Res Ther; 2022 Jun; 13(1):274. PubMed ID: 35739577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.
    Gori JL; Butler JM; Kunar B; Poulos MG; Ginsberg M; Nolan DJ; Norgaard ZK; Adair JE; Rafii S; Kiem HP
    Stem Cells Transl Med; 2017 Mar; 6(3):864-876. PubMed ID: 28297579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia.
    Lu D; Xu Z; Peng Z; Yang Y; Song B; Xiong Z; Ma Z; Guan H; Chen B; Nakamura Y; Zeng J; Liu N; Sun X; Chen D
    Front Genet; 2022; 13():881937. PubMed ID: 35656314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.
    Venkatesan V; Christopher AC; Rhiel M; Azhagiri MKK; Babu P; Walavalkar K; Saravanan B; Andrieux G; Rangaraj S; Srinivasan S; Karuppusamy KV; Jacob A; Bagchi A; Pai AA; Nakamura Y; Kurita R; Balasubramanian P; Pai R; Marepally SK; Mohankumar KM; Velayudhan SR; Boerries M; Notani D; Cathomen T; Srivastava A; Thangavel S
    Mol Ther Nucleic Acids; 2023 Jun; 32():671-688. PubMed ID: 37215154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.
    Leonard A; Bonifacino A; Dominical VM; Luo M; Haro-Mora JJ; Demirci S; Uchida N; Pierciey FJ; Tisdale JF
    Br J Haematol; 2019 Jul; 186(2):286-299. PubMed ID: 30972754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates.
    Romero Z; Lomova A; Said S; Miggelbrink A; Kuo CY; Campo-Fernandez B; Hoban MD; Masiuk KE; Clark DN; Long J; Sanchez JM; Velez M; Miyahira E; Zhang R; Brown D; Wang X; Kurmangaliyev YZ; Hollis RP; Kohn DB
    Mol Ther; 2019 Aug; 27(8):1389-1406. PubMed ID: 31178391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies.
    Ureña-Bailén G; Block M; Grandi T; Aivazidou F; Quednau J; Krenz D; Daniel-Moreno A; Lamsfus-Calle A; Epting T; Handgretinger R; Wild S; Mezger M
    CRISPR J; 2023 Feb; 6(1):5-16. PubMed ID: 36662546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β
    Fu B; Liao J; Chen S; Li W; Wang Q; Hu J; Yang F; Hsiao S; Jiang Y; Wang L; Chen F; Zhang Y; Wang X; Li D; Liu M; Wu Y
    Nat Med; 2022 Aug; 28(8):1573-1580. PubMed ID: 35922667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic-screening generates active novel fetal globin-inducers that downregulate Bcl11a in a monkey model.
    Makino T; Haruyama M; Katayama K; Terashima H; Tsunemi T; Miyazaki K; Terakawa M; Yamashiro K; Yoshioka R; Maeda H
    Biochem Pharmacol; 2020 Jan; 171():113717. PubMed ID: 31751536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells.
    Mehta S; Buyanbat A; Kai Y; Karayel O; Goldman SR; Seruggia D; Zhang K; Fujiwara Y; Donovan KA; Zhu Q; Yang H; Nabet B; Gray NS; Mann M; Fischer ES; Adelman K; Orkin SH
    Cell Chem Biol; 2022 Aug; 29(8):1273-1287.e8. PubMed ID: 35839780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates.
    Peterson CW; Wang J; Norman KK; Norgaard ZK; Humbert O; Tse CK; Yan JJ; Trimble RG; Shivak DA; Rebar EJ; Gregory PD; Holmes MC; Kiem HP
    Blood; 2016 May; 127(20):2416-26. PubMed ID: 26980728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses.
    Frati G; Brusson M; Sartre G; Mlayah B; Felix T; Chalumeau A; Antoniou P; Hardouin G; Concordet JP; Romano O; Turchiano G; Miccio A
    Mol Ther; 2024 Dec; 32(12):4337-4352. PubMed ID: 39044427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.